The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology
Open accessAbstract
Background: Patients presenting with acute interstitial nephritis (AIN) of unknown aetiology, probably the earliest presentation of chronic kidney disease of unknown aetiology (CKDu), have been treated with oral prednisolone and doxycycline by physicians in Sri Lanka. This trial assessed the effectiveness of prednisolone and doxycycline based on eGFR changes at 6 months in patients with AIN of unknown aetiology. Method: A randomized clinical trial with a 2 × 2 factorial design for patients presenting with AIN of unknown aetiology (n = 59) was enacted to compare treatments with; A-prednisolone, B-doxycycline, C-both treatments together, and D-neither. The primary outcome was a recovery of patients’ presenting renal function to eGFR categories: 61–90 ml/min/1.73m 2 (complete remission– CR) to 31–60 ml/min/1.73m 2 (partial remission– PR) and 0–30 ml/min/1.73m 2 no remission (NR) by 6 months. A secondary outcome was progression-free survival (not reaching < 30 ml/min/1.73m 2 eGFR), by 6–36 months. Analysis was by intention to treat. Results: Seventy patients compatible with a clinical diagnosis of AIN were biopsied for eligibility; 59 AIN of unknown aetiology were enrolled, A = 15, B = 15, C = 14 and D = 15 randomly allocated to each group. Baseline characteristics were similar between groups. The number of patients with CR, PR and NR, respectively, by 6 months, in group A 3:8:2, group B 2:8:3 and group C 8:5:0 was compared with group D 8:6:1. There were no significant differences found between groups A vs. D (p = 0.2), B vs. D (p = 0.1) and C vs. D (p = 0.4). In an exploratory analysis, progression-free survival in prednisolone-treated (A + C) arms was 0/29 (100%) in comparison to 25/30 (83%) in those not so treated (B + D) arms, and the log-rank test was p = 0.02, whereas no such difference found (p = 0.60) between doxycycline-treated (B + C) arms 27/29 (93%) vs those not so treated (A + D) arms 27/30 (90%). Conclusion: Prednisolone and doxycycline were not beneficial for the earliest presentation of CKDu at 6 months. However, there is a potential benefit of prednisolone on the long-term outcome of CKDu. An adequately powered steroid trial using patients reaching < 30 ml/min/1.73m 2 eGFR by 3 years, as an outcome is warranted for AIN of unknown aetiology. Trial registration: Sri Lanka Clinical Trial Registry SLCTR/2014/007, Registered on the 31st of March 2014.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Chronic Kidney Disease Associated With Environmental Toxins and Exposures
Soderland, P., Lovekar, S., Weiner, D. E., Brooks, D. R., & Kaufman, J. S. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.03.011 · Cited by 250
Tubulointerstitial nephritis: diagnosis, treatment, and monitoring
Joyce, E., Glasner, P., Ranganathan, S., & Swiatecka-Urban, A. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3394-5 · Cited by 186
CKD of Uncertain Etiology: A Systematic Review
Lunyera, J., Mohottige, D., Isenburg, M. V., Jeuland, M., Patel, U. D., & Stanifer, J. W. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07500715 · Cited by 181
Acute interstitial nephritis â a reappraisal and update
Raghavan, R., & Eknoyan, G. (2014) · Clinical Nephrology · doi:10.5414/cn10838 · Cited by 180
Endemic Nephropathy Around the World
Gifford, F. J., Gifford, R. M., Eddleston, M., & Dhaun, N. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2016.11.003 · Cited by 172
Nanayakkara, S., Komiya, T., Ratnatunga, N. V. I., Senevirathna, L., Harada, K. H., Hitomi, T., Gobe, G. C., Muso, E., Abeysekera, T. D. J., & Koizumi, A. (2011) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-011-0243-9 · Cited by 147
Self-citationAcute interstitial nephritis – a reappraisal and update
Raghavan, R., & Eknoyan, G. (2014) · Clinical Nephrology · doi:10.5414/cn108386 · Cited by 141
Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology
Yang, C. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000480691 · Cited by 117
Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy
Wijkström, J., González-Quiroz, M., Hernandez, M., Trujillo, Z., Hultenby, K. R., Ring, A., Söderberg, M. P., Aragón, A., Elinder, C., & Wernerson, A. M. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.036 · Cited by 114
Cited by
Chronic kidney disease with unknown cause across the global spectrum
Nast, C. C. (2023) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000874 · Cited by 64
Miao, J., Thongprayoon, C., Krisanapan, P., Buglioni, A., Craici, I. M., & Cheungpasitporn, W. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.026 · Cited by 18
A Systematic Review of Treatment for Acute Interstitial Nephritis
Yu, Y., Biroš, E., Chang, X., & Mallett, A. J. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.05.009 · Cited by 6
Nanayakkara, N. (2023) · Journal of the Ceylon College of Physicians · doi:10.4038/jccp.v54i2.8025
Self-citationYoshida, N., Suzuki, Y., Hitaka, M., Yamazaki, K., & Ohashi, Y. (2025) · Cureus · doi:10.7759/cureus.87304
Metadata
- Authors
- Badurdeen, Z., Ratnatunga, N., Abeysekera, T., Wazil, A. W. M., Rajakrishna, P. N., Thinnarachchi, J. P., Welagedera, D. D., Ratnayake, N., Alwis, A. P. D., Abeysundara, H., Kumarasiri, R., Taylor, R., & Nanayakkara, N.
- Affiliations
- University of Peradeniya (LK)
- Teaching Hospital Kandy (LK)
- UNSW Sydney (AU)
- Corresponding author
- Badurdeen, Zeid
- ORCID
- Venue
- Trials
- Published
- 2023-01-05
- Volume
- 24
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC9814196
- OpenAlex
- W4313495411
- Cited by
- 6
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Trials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Peradeniya
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- acute interstitial nephritis, chronic kidney disease of unknown aetiology, prednisolone, doxycycline, corticosteroid therapy, progression-free survival, treatment effectiveness, Sri Lanka
- MeSH terms
- Doxycycline, Glucocorticoids, Humans, Nephritis, Interstitial, Prednisolone, Sri Lanka, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology. https://app.cochat.ai/papers/10.1186/s13063-022-07056-4
- The paper
- Badurdeen, Z., Ratnatunga, N., Abeysekera, T., Wazil, A. W. M., Rajakrishna, P. N., Thinnarachchi, J. P., Welagedera, D. D., Ratnayake, N., Alwis, A. P. D., Abeysundara, H., Kumarasiri, R., Taylor, R., & Nanayakkara, N. (2023). Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology. Trials. https://doi.org/10.1186/s13063-022-07056-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.